{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:34:53Z","timestamp":1787070893550,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Low-density lipoprotein receptor-related protein-2 (LRP2), also called megalin, is a multi-ligand receptor of the LDL receptor gene family mediating reabsorption of ligands like Apo-A1. Type 2 diabetes mellitus (T2DM) may possibly disrupt megalin functions as it is found to be regulated by insulin. This might cause cardiovascular complications due to derangement in lipoprotein metabolism. The current study was carried out to assess the serum megalin levels among T2DM individuals with cardiovascular complications in the Indian population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This was a cross-sectional study involving 80 patients with T2DM. 40 T2DM patients with known cardiovascular disease were selected as cases and 40 of those without evidence of cardiovascular disease were selected as controls. Demographic details, DM duration and class of oral hypoglycemic agents (OHA) used were collected from medical records while details of lipid profile, fasting glucose, serum creatinine and urea were collected from laboratory information system. Serum megalin levels were estimated using left-over samples by ELISA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The study groups showed no statistical significance in baseline laboratory parameters except for serum creatinine and low density lipoprotein cholesterol (LDL-c). Mean serum megalin levels were statistically insignificant between cases and controls (0.91 \u00b1 0.78 ng\/mL vs. 0.85 \u00b1 0.69 ng\/mL,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      0.74).The subgroup analysis of serum megalin levels based on OHA consumption among cases was also statistically insignificant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      0.056). Pearson\u2019s correlational analysis was statistically insignificant between serum megalin and lipid profile parameters among cases (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Serum megalin alone may not serve as a biomarker for cardiovascular disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_989_24","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T04:01:29Z","timestamp":1731729689000},"page":"5240-5243","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Serum megalin levels in type-2 diabetes mellitus with and without cardiovascular disease"],"prefix":"10.4103","volume":"13","author":[{"given":"Sujatha","family":"Rajaragupathy","sequence":"first","affiliation":[{"name":"Department of Biochemistry, PSG Institute of Medical Sciences and Research, Coimbatore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Ponnusamy","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, PSG Institute of Medical Sciences and Research, Coimbatore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanalakshmi","family":"Balasundararaj","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, PSG Institute of Medical Sciences and Research, Coimbatore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhiya","family":"Venkatesan","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, PSG Institute of Medical Sciences and Research, Coimbatore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayagowri","family":"Karthikeyan","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, PSG Institute of Medical Sciences and Research, Coimbatore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"key":"R2-20250129","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.4103\/ijo.IJO_1627_21","article-title":"Epidemiology of type 2 diabetes in India","volume":"69","author":"Mohan","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R3-20250129","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"Rao Kondapally Seshasai","year":"2011","journal-title":"N Engl J Med"},{"key":"R4-20250129","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1161\/01.CIR.100.10.1134","article-title":"Diabetes and cardiovascular disease:A statement for healthcare professionals from the American Heart Association","volume":"100","author":"Grundy","year":"1999","journal-title":"Circulation"},{"key":"R5-20250129","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.116.022194","article-title":"Clinical update:Cardiovascular disease in diabetes mellitus:Atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus-mechanisms, management, and clinical considerations","volume":"133","author":"Low Wang","year":"2016","journal-title":"Circulation"},{"key":"R6-20250129","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.1073\/pnas.79.18.5557","article-title":"The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border","volume":"79","author":"Kerjaschki","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"R7-20250129","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3390\/membranes4030333","article-title":"The endocytic receptor megalin and its associated proteins in proximal tubule epithelial cells","volume":"4","author":"De","year":"2014","journal-title":"Membranes"},{"key":"R8-20250129","doi-asserted-by":"crossref","first-page":"3491764","DOI":"10.1155\/2020\/3491764","article-title":"Lipoprotein(a) the insurgent:A new insight into the structure, function, metabolism, pathogenicity, and medications affecting lipoprotein(a) molecule","volume":"2020","author":"Jawi","year":"2020","journal-title":"J Lipids"},{"key":"R9-20250129","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1050-1738(01)00080-9","article-title":"Cubilin and megalin:Partners in lipoprotein and vitamin metabolism","volume":"11","author":"Barth","year":"2001","journal-title":"Trends Cardiovasc Med"},{"key":"R10-20250129","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4067\/S0716-97602011000100012","article-title":"New insights into the roles of megalin\/LRP2 and the regulation of its functional expression","volume":"44","author":"Marzolo","year":"2011","journal-title":"Biol Res"},{"key":"R11-20250129","doi-asserted-by":"crossref","first-page":"F1191","DOI":"10.1152\/ajprenal.00210.2018","article-title":"Increased megalin expression in early type 2 diabetes:Role of insulin-signaling pathways","volume":"315","author":"Bryniarski","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"R12-20250129","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/ATVBAHA.118.311817","article-title":"Angiotensinogen and megalin interactions contribute to atherosclerosis-brief report","volume":"39","author":"Ye","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R13-20250129","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1038\/s41467-020-15963-w","article-title":"Apolipoprotein J is a hepatokine regulating muscle glucose metabolism and insulin sensitivity","volume":"11","author":"Seo","year":"2020","journal-title":"Nat Commun"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_989_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:38:27Z","timestamp":1787067507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_989_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":12,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_989_24","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"2024-06-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}